EMEA-001142-PIP02-16-M02 - paediatric investigation plan
ceftolozane
tazobactam
PIPHuman
Key facts
- Invented name
- Zerbaxa
- Active substance
- ceftolozane
- tazobactam
- Therapeutic area
- Infections and infestations
- Decision number
- P/0381/2024
- PIP number
- EMEA-001142-PIP02-16-M02
- Pharmaceutical form(s)
- Powder for concentrate for solution for infusion
- Condition(s) / indication(s)
- Treatment of pneumonia
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Merck Sharp & Dohme B.V.
E-mail: pip.information@msd.com
Tel.: +33 180464738- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date
- Compliance check done
- No